313 related articles for article (PubMed ID: 37279000)
1. Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Xie X; Johnston SC; Wang A; Xu Q; Bath PM; Pan Y; Li H; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Xu A; Jing J; Meng X; Wang Y
JAMA Netw Open; 2023 Jun; 6(6):e2317037. PubMed ID: 37279000
[TBL] [Abstract][Full Text] [Related]
2. Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial.
Pan Y; Meng X; Jin A; Johnston SC; Li H; Bath PM; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Yang H; Cheng J; Wang Z; Wang Y
JAMA Neurol; 2022 Aug; 79(8):739-745. PubMed ID: 35727586
[TBL] [Abstract][Full Text] [Related]
3. Ticagrelor Aspirin vs Clopidogrel Aspirin in
Wang A; Meng X; Tian X; Zuo Y; Bath PM; Li H; Xie X; Jing J; Lin J; Wang Y; Zhao X; Liu L; Li Z; Jiang Y; Xu J; Wang F; Chen W; Cao M; Li J; Wang Y
Neurology; 2023 Jan; 100(5):e497-e504. PubMed ID: 36535779
[TBL] [Abstract][Full Text] [Related]
4. Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack.
Wang Y; Zhao X; Lin J; Li H; Johnston SC; Lin Y; Pan Y; Liu L; Wang D; Wang C; Meng X; Xu J; Wang Y;
JAMA; 2016 Jul; 316(1):70-8. PubMed ID: 27348249
[TBL] [Abstract][Full Text] [Related]
5. One-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in
Meng X; Wang A; Tian X; Johnston C; Li H; Bath PM; Xu Q; Zhang Y; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Wang Y
Neurology; 2024 Feb; 102(3):e207809. PubMed ID: 38181311
[TBL] [Abstract][Full Text] [Related]
6. Ticagrelor versus Clopidogrel in
Wang Y; Meng X; Wang A; Xie X; Pan Y; Johnston SC; Li H; Bath PM; Dong Q; Xu A; Jing J; Lin J; Niu S; Wang Y; Zhao X; Li Z; Jiang Y; Li W; Liu L; Xu J; Chang L; Wang L; Zhuang X; Zhao J; Feng Y; Man H; Li G; Wang B;
N Engl J Med; 2021 Dec; 385(27):2520-2530. PubMed ID: 34708996
[TBL] [Abstract][Full Text] [Related]
7. Genotype-Guided Dual Antiplatelet Therapy in Minor Stroke or Transient Ischemic Attack With a Single Small Subcortical Infarction.
Liu H; Jing J; Wang A; Xu Q; Meng X; Li H; Li Z; Wang Y
Neurology; 2023 Apr; 100(16):e1643-e1654. PubMed ID: 36697242
[TBL] [Abstract][Full Text] [Related]
8. Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial.
Pan Y; Chen W; Wang Y; Li H; Johnston SC; Simon T; Zhao X; Liu L; Wang D; Meng X; Wang Y;
JAMA Neurol; 2019 May; 76(5):552-560. PubMed ID: 30742211
[TBL] [Abstract][Full Text] [Related]
9. Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial.
Pereira NL; Farkouh ME; So D; Lennon R; Geller N; Mathew V; Bell M; Bae JH; Jeong MH; Chavez I; Gordon P; Abbott JD; Cagin C; Baudhuin L; Fu YP; Goodman SG; Hasan A; Iturriaga E; Lerman A; Sidhu M; Tanguay JF; Wang L; Weinshilboum R; Welsh R; Rosenberg Y; Bailey K; Rihal C
JAMA; 2020 Aug; 324(8):761-771. PubMed ID: 32840598
[TBL] [Abstract][Full Text] [Related]
10. Ticagrelor-Aspirin Versus Clopidogrel-Aspirin Among
Wang A; Xie X; Tian X; Johnston SC; Li H; Bath PM; Zuo Y; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Meng X; Wang Y
Ann Intern Med; 2022 Nov; 175(11):1534-1542. PubMed ID: 36315949
[TBL] [Abstract][Full Text] [Related]
11. Impact of body mass index on efficacy and safety of ticagrelor versus clopidogrel in patients with minor stroke or transient ischemic attack.
Zhang J; Wang A; Tian X; Meng X; Xie X; Jing J; Lin J; Wang Y; Li Z; Liu L; Li H; Jiang Y; Zhao X; Wang Y
CMAJ; 2023 Jul; 195(26):E897-E904. PubMed ID: 37429630
[TBL] [Abstract][Full Text] [Related]
12. Ticagrelor Versus Clopidogrel in Minor Stroke or Transient Ischemic Attack With Intracranial Artery Stenosis: A Post Hoc Analysis of CHANCE-2.
Wang C; Jia W; Jing J; Meng X; Wang A; Xu Q; Zhang X; Pan Y; Xie X; Johnston SC; Bath PM; Lin J; Jiang Y; Li H; Wang Y; Zhao X; Liu L; Li Z; Wang Y;
J Am Heart Assoc; 2023 Nov; 12(21):e031611. PubMed ID: 37889172
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by
Zhou M; Chen W; Pan Y; Lin Y; Meng X; Zhao X; Liu L; Lin J; Li H; Wang Y; Wang Y
Aging (Albany NY); 2020 Dec; 13(3):3994-4006. PubMed ID: 33411687
[TBL] [Abstract][Full Text] [Related]
14. Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial.
Wang Y; Chen W; Lin Y; Meng X; Chen G; Wang Z; Wu J; Wang D; Li J; Cao Y; Xu Y; Zhang G; Li X; Pan Y; Li H; Zhao X; Liu L; Lin J; Dong K; Jing J; Johnston SC; Wang D; Wang Y;
BMJ; 2019 Jun; 365():l2211. PubMed ID: 31171523
[TBL] [Abstract][Full Text] [Related]
15. Dual Antiplatelet Therapy After Embolic Stroke of Undetermined Source: A Subgroup Analysis of the CHANCE-2 Trial.
Xie X; Jing J; Meng X; Johnston SC; Bath PM; Li Z; Zhao X; Wang Y; Xu Q; Wang A; Jiang Y; Li H; Wang Y;
Stroke; 2024 Jul; 55(7):1739-1747. PubMed ID: 38860396
[TBL] [Abstract][Full Text] [Related]
16. Dual Antiplatelet Therapies and Causes in Minor Stroke or Transient Ischemic Attack: A Prespecified Analysis in the CHANCE-2 Trial.
Xie X; Jing J; Meng X; Claiborne Johnston S; Bath PM; Li Z; Zhao X; Liu L; Wang Y; Xu Q; Wang A; Jiang Y; Li H; Wang Y;
Stroke; 2023 Sep; 54(9):2241-2250. PubMed ID: 37548009
[TBL] [Abstract][Full Text] [Related]
17. High-Dose Clopidogrel versus Ticagrelor in CYP2C19 intermediate or poor metabolizers after percutaneous coronary intervention: A Meta-Analysis of Randomized Trials.
Sheng XY; An HJ; He YY; Ye YF; Zhao JL; Li S
J Clin Pharm Ther; 2022 Aug; 47(8):1112-1121. PubMed ID: 35396752
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of ticagrelor versus clopidogrel by homocysteine levels on risk of recurrent stroke: a post hoc analysis of the CHANCE-2 trial.
Wang A; Tian X; Xie X; Li H; Bath PM; Jing J; Lin J; Wang Y; Zhao X; Li Z; Liu L; Wang Y; Meng X
CMAJ; 2024 Feb; 196(5):E149-E156. PubMed ID: 38346785
[TBL] [Abstract][Full Text] [Related]
19. Stroke Recurrence and Antiplatelets in Posterior Versus Anterior Circulation Minor Stroke or Transient Ischemic Attack.
Liu H; Jing J; Wang A; Xu Q; Meng X; Li H; Li Z; Wang Y
Stroke; 2023 Apr; 54(4):964-972. PubMed ID: 36789773
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of aspirin-ticagrelor vs. aspirin-clopidogrel in ischemic stroke patients with cerebral artery stenting.
Liu C; Liu M; Yang X; Luo T; Wang J; Li G
Clin Neurol Neurosurg; 2024 Apr; 239():108229. PubMed ID: 38479036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
